NCT04722900 PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes
| NCT ID | NCT04722900 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Offspring Exposed to GDM and Control |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-01-15 |
| Primary Completion | 2036-01-15 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Gestational diabetes is the most common complication during pregrancy. With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated. Treatment comprises modification of diet and in some cases taking medication. This treatment lowers undesirable events like macrosomia or premature birth. However, unitl gestational diabetes is diagnosed the fetus is exposed to increased intrauterine glucose levels. The long-term effects of a well-managed gestational diabetes on the development of the offspring is still not well understood. Therefore, the PREG - Offspring study investigates several aspects of development in children from healthy and gestational diabetes mothers until adulthood.
Eligibility Criteria
Inclusion Criteria: * signed informed consent provided by child and parent * documented oral glucose tolerance test of the mother during pregnancy * adequate management of gestational diabetes until birth Exclusion Criteria: * severe malformation that makes an examination impossible * existent of coagulation disorder with increased risk of bleeding after blood sampling